Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Gains from Investment Securities (2022 - 2025)

Kura Oncology has reported Gains from Investment Securities over the past 4 years, most recently at $1.0 million for Q4 2025.

  • Quarterly Gains from Investment Securities fell 92.14% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 92.14% year-over-year, with the annual reading at $1.0 million for FY2025, 92.14% down from the prior year.
  • Gains from Investment Securities was $1.0 million for Q4 2025 at Kura Oncology, up from $969417.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $12.9 million in Q4 2024 and troughed at $969417.0 in Q3 2025.
  • The 4-year median for Gains from Investment Securities is $1.2 million (2025), against an average of $5.1 million.
  • Year-over-year, Gains from Investment Securities rose 25.31% in 2024 and then plummeted 92.14% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at $8.4 million in 2022, then grew by 22.22% to $10.3 million in 2023, then increased by 25.31% to $12.9 million in 2024, then plummeted by 92.14% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Gains from Investment Securities are $1.0 million (Q4 2025), $969417.0 (Q3 2025), and $1.2 million (Q2 2025).